Treatments of chronic fatigue syndrome and its debilitating comorbidities: a 12-year population-based study

Overview of attention for article published in Journal of Translational Medicine, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

blogs: 1 blog
twitter: 4 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 65 Mendeley

Summary Blogs X Facebook Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 44,290 followers.

@doctormacias Todos los medicamentos que inhiben la recaptura de noradrenalina (antidepresivos duales) o medicamentos que activen el sistema reticular activador ascendente como modafinilo SI han demostrado mejorar escalas de fatiga y cansancio en distintas

28 Apr 2023

Reply Repost Favourite

RT @PlzSolveCFS: 1. Treatments of chronic fatigue syndrome and its debilitating comorbidities: a 12-year population-based study. J Transl M…

15 Jul 2022

Reply Repost Favourite

RT @PlzSolveCFS: 1. Treatments of chronic fatigue syndrome and its debilitating comorbidities: a 12-year population-based study. J Transl M…

13 Jul 2022

Reply Repost Favourite

1. Treatments of chronic fatigue syndrome and its debilitating comorbidities: a 12-year population-based study. J Transl Med (impact factor: 5.5) (2022) https://t.co/EqqLzBaFc9

13 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.